Gregory Adams

Company: Elucida Oncology

Job title: Chief Scientific Officer

Seminars:

Folate Receptor Alpha Targeted Topiosomerase 1 CDC For Platinum Resistant Ovarian Cancer 5:00 pm

Overviewing novel targeted CDot Conjugates for the treatment of Folate Receptor Alpha over-expressing tumors Reviewing how CDC multivalent tumor targeting and high payload loading allows for the more effective killing of tumors with lower target antigen expression Exploring how Elucida’s CDC can be expanded into other FR+/Topo1 responsive indicationsRead more

day: day 2- pm